Apogee Therapeutics (APGE) Long-Term Investments (2024 - 2026)
Apogee Therapeutics (APGE) reported Long-Term Investments of $198.4 million for Q1 2026, up 17.99% year-over-year from $168.1 million in Q1 2025, and up 14.83% quarter-over-quarter from $172.7 million in Q4 2025.
Apogee Therapeutics (APGE) Long-Term Investments (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 3 years of Long-Term Investments data on file, last reported at $198.4 million in Q1 2026.
- Long-Term Investments for Q1 2026 came in at $198.4 million, up 17.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $198.4 million (up 17.99% YoY), and the FY2025 annual result was $172.7 million, down 17.91% from the prior year.
- Long-Term Investments climbed to $198.4 million in Q1 2026 per APGE's latest filing, from $172.7 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $227.7 million in Q3 2024 and troughed at $61.6 million in Q3 2025.
- A 3-year average of $158.5 million and a median of $170.4 million in 2025 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2025 and 2026: Long-Term Investments tumbled 72.95% in 2025, then advanced 17.99% in 2026.
- A 3-year view of Long-Term Investments shows it stood at $210.4 million in 2024, then decreased by 17.91% to $172.7 million in 2025, then rose by 14.83% to $198.4 million in 2026.
- Business Quant data shows APGE's Long-Term Investments at $198.4 million in Q1 2026, $172.7 million in Q4 2025, and $61.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Apogee Therapeutics | 6.15 Bn | 5.09 Bn | - | 198.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 198.35 Mn |
| Dec 31, 2025 | 172.73 Mn |
| Sep 30, 2025 | 61.60 Mn |
| Jun 30, 2025 | 115.80 Mn |
| Mar 31, 2025 | 168.11 Mn |
| Dec 31, 2024 | 210.42 Mn |
| Sep 30, 2024 | 227.75 Mn |
| Jun 30, 2024 | 113.40 Mn |